This finding reinforces the importance of GAT-1 in regulating inhibitory neurotransmission and maintaining the excitatory–inhibitory balance in the brain, highlighting its potential as a therapeutic target for specific interventions in epilepsy and paving the way for future investigations into GAT-1 modulation as a strategy to control neuronal hyperexcitability. The gene discussed is SLC6A1; the disease is epilepsy.